Martinsried – PELOBiotech GmbH, one of the leading Cell Culture solution experts worldwide, is happy to introduce SpheroSeev & HydroSeev, recombinant biopolymers similar to spider silk. They are produced by Seevix, an Israelian biotech company, and can be used together with hydrogels (e.g. Matrigel) to stabilize hydrogels for long-term culture. “As the need for long-term cell culture is rising and consistent and reproducible results are needed,” says Dr. Peter Frost, CEO PELOBiotech, “we are happy to ease the path for this easy, outstanding solution to the European scientific community.“ Therefore PELOBiotech is strengthening its position as 3D cell culture specialist and widening its broad portfolio of solution-demanded 3D cell culture tools.
Seevix products mimic natural tissue morphology and cell behavior for purposes of hepatotoxicity & ADME-Tox, drug discovery, stem cell research, cancer research, tissue engineering & 3D bioprinting and cultured meat. The fibers’ nano and microarchitecture mimic the natural Extracellular Matrix (ECM), providing a tissue-like environment for cells.
The highly porous structure enables better access to oxygen and nutrients, thereby reducing the necrotic core and supporting prolonged viability and functionality. High strength and elasticity provide mechanical cushioning and protection to individual cells within the organoid. The large surface area enables the delivery of active ingredients to the core of the spheroids.
About Seevix:
Seevix Material Sciences is a biotech company founded in 2014 and operating in the synthetic biology and bio-industrial sector. It produces high-strength patented SVX™ spider silk by means of unique recombinant DNA technologies, which allow it to replicate the natural process of spider silk creation. Its product is animal-free, vegan, eco-friendly and sustainable. Using SVX, Seevix generates novel materials whose high-performance properties, sustainability and biocompatibility can radically improve existing products and provide solutions for unmet needs in many industries, such as cosmetics, textiles, sports, consumer healthcare, medical devices and scaffolds for tissue modeling and cultured meat.
Über die PELOBIOTECH GmbH
PELOBIOTECH GmbH is based in Planegg (Munich area), Germany, and is a leading distributor of high-quality and innovative life science research tools and reagents with a focus on 3D cell culture. With over 20,000 products it has one of the worldwide broadest portfolios of primary cell and stem cell biology solutions.
With its worldwide network of innovative and highly specialized companies, PELOBiotech is a scientist’s first place to go.
Pick the right tools:
– Human/Animal Primary and Stem Cells
corresponding media, also defined or xeno-free media
-ES/iPS Cells, Media, & Tools
– modified (KD/KO) or labeled Primary/Stem cells
– Customized Tissue Sourcing & Cell Isolation
– Cell Culture Tools
– 3D Cell Culture technologies and models easy-to-use & Tools
– 3D-micro tissue ready-to-use
– Biomatrix (ECM), Organospeciific ECM, Smart Hydrogels
– Reprogramming Tools & Small Molecules
– Angiogenesis-Modelle
– MicroMatrix-Test
– Cell Culture Tools: Recombinant Proteins like Cytokines, Growth factors
Antibodies,
– Midifluidic chambers, Microfluidic Chips
– High-performance microsphere products
– Premium Grade & GMP
– Cell-based assays
– Cold- and Cryopreservation media
Firmenkontakt und Herausgeber der Meldung:
PELOBIOTECH GmbH
Am Klopferspitz 19
82152 Planegg/Martinsried
Telefon: +49 (89) 51777140
Telefax: +49 (89) 51777160
http://www.pelobiotech.com
Ansprechpartner:
Christiane Büchsel
Head of Marketing
Telefon: +49 (89) 5172865911
E-Mail: christiane.buechsel@pelobiotech.com
Head of Marketing
Telefon: +49 (89) 5172865911
E-Mail: christiane.buechsel@pelobiotech.com
Weiterführende Links
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.
